Emerald Health Therapeutics Stock Analysis
Technical stock analysis for Wed 12'th Dec 2018
Emerald Health Therapeutics fell by -0.96% in the last day from $2.08 to $2.06 The price has fallen in 7 of the last 10 days and is down by -20.16% for this period. Volume has increased in the last day by 4 780 shares, but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 220 909 shares bought and sold for approximately $455 073.00.
Emerald Health Therapeutics lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -34.96% during the next 3 months and, with 90% probability hold a price between $1.03 and $2.14 at the end of this period.
There are few to none technical positive signals at the moment. Emerald Health Therapeutics holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $2.78. On a fall, the stock will find some support from the short-term average at $2.04. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Tuesday December 11, 2018, which indicates further falls until a new bottom pivot has been found. Emerald Health Therapeutics gained volume on the last day, but on falling prices. In technical terms this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-off's".
Relative Strength Index (RSI)
RSI14 is 32 and the stock is currently not being overbought or oversold
Support & Resistance
Emerald Health Therapeutics finds support from accumulated volume at $2.04.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.08 between high and low, or 3.90%. For the last week, the stock has had a daily average volatility of 10.64%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Emerald Health Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
|Get a PRO membership|
To Reveal Top 5 Sell Candidates
Follow Auto Portfolios gaining up to 30%.
Disclaimer: There is no guarantee against any loss. Your capital is at risk.
Click to become a PRO member